Britannia Life Sciences Inc Financial Overview
Britannia Life Sciences Inc's market cap is currently C$14.60M. The company's EPS TTM is C$-0.002; its P/E ratio is -1.80; Britannia Life Sciences Inc is scheduled to report earnings on December 1, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
